Wikidata

(Q57539302)

English

Abstract CT323: Accelerated phase I trial of two schedules of the combination of the PARP inhibitor olaparib and AKT inhibitor AZD5363 using a novel intrapatient dose escalation design in advanced cancer patients

No description defined

In more languages

Statements

title
Abstract CT323: Accelerated phase I trial of two schedules of the combination of the PARP inhibitor olaparib and AKT inhibitor AZD5363 using a novel intrapatient dose escalation design in advanced cancer patients (English)
0 references
author name string
Vasiliki Michalarea
series ordinal
1
0 references
David Lorente
series ordinal
2
0 references
Juanita Lopez
series ordinal
3
0 references
Suzanne Carreira
series ordinal
4
0 references
Hasina Hassam
series ordinal
5
0 references
Mona Parmar
series ordinal
6
0 references
Nitharsan Sathiyayogan
series ordinal
7
0 references
Alison Turner
series ordinal
8
0 references
Emma Hall
series ordinal
9
0 references
Sonia Serrano Fandos
series ordinal
10
0 references
Satyanarayana Seeramreddi
series ordinal
11
0 references
Shaun Decordova
series ordinal
12
0 references
Karen Swales
series ordinal
13
0 references
Ruth Ruddle
series ordinal
14
0 references
Florence Raynaud
series ordinal
15
0 references
Nina Tunariu
series ordinal
16
0 references
Gerhardt Attard
series ordinal
17
0 references
L. Rhoda Molife
series ordinal
18
0 references
Udai Banerji
series ordinal
19
0 references
Ruth Plummer
series ordinal
20
0 references
Johann S. de Bono
series ordinal
21
0 references
Timothy A. Yap
series ordinal
22
0 references
publication date
1 August 2015
0 references
volume
75
0 references
issue
15 Supplement
0 references
page(s)
CT323-CT323
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q57539302&oldid=1977801378"